Sanofi claims high-ris­es neigh­bor­ing its Toron­to fa­cil­i­ty would pose 'na­tion­al se­cu­ri­ty' threat

Sanofi isn’t so hap­py with one of its neigh­bors. The French phar­ma gi­ant is go­ing to bat­tle against a Cana­di­an de­vel­op­er’s pro­pos­al to build two, 30-plus-sto­ry res­i­den­tial tow­ers less than half a mile away from its Toron­to fa­cil­i­ty, cit­ing “na­tion­al se­cu­ri­ty con­cerns.”

The news comes just un­der a year af­ter Sanofi an­nounced it’s dump­ing more than $676 mil­lion in­to a new vac­cine man­u­fac­tur­ing fa­cil­i­ty at the Toron­to site, which will be re­spon­si­ble for ad­di­tion­al anti­gen and fill­ing ca­pac­i­ty for its Flu­zone high-dose quadri­va­lent vac­cine. The new fa­cil­i­ty should be up and run­ning in 2026, the com­pa­ny said back in March.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.